Usage Instructions Inject once weekly under the skin (abdomen, thigh, upper arm) Start at 0.25 mg weekly for 4 weeks, then increase as directed Doses may be raised to 0.5 mg, 1 mg, or 2 mg weekly Use at the same time each week (with or without food) Rotate injection sites to prevent skin irritation Side Effects Nausea, vomiting, diarrhea or constipation Loss of appetite Fatigue or headache Rare: pancreatitis, gallbladder problems, kidney injury, allergic reactions Increased risk of thyroid tumors in animal studies (not seen in humans) Side effects are often mild and improve with time
The medication is eliminated primarily through proteolytic degradationmeaning it is broken down by enzymes into smaller peptide fragments and amino acids, which are then processed through normal metabolic pathways
Starting at $149/month, compounded semaglutide becomes an evidence-based, affordable solution for individuals seeking to lower cholesterol, lose weight, and reduce cardiovascular disease risk simultaneously
The Obesity Action Coalition and The Obesity Society sent a letter urging the FDA to enforce federal regulations around compounding following the recent resolution of GLP-1 medicine shortages